Colonnese Mark P

Avg. Two Year Performance

(36%) Avg. Purchase Return
(17%) Compound
71% Avg. Sale Return
31% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%14%(6%)(20%)(36%)
Purchase Success Rate1 of 11 of 10 of 10 of 10 of 1
Average Sale Return18%19%28%35%71%
Sale Success Rate2 of 32 of 32 of 32 of 32 of 3
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 7.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Other

VP Commercial Operations & CFO:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Electronics » Scientific & Technical Instruments

Chief Financial Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Delivery

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--